Evidence map›Paper›PMID 42766712›Full record

ArticleJMIR AI2026

Interpretable Multihorizon Glucose Forecasting for Assessing Nutritional Information Impact in Type 1 Diabetes Management: Model Development and Validation Study.

Carlos Gallardo-García, M Elena Hernando, David Subías, Mercedes Rigla, Gema García-Sáez

Abstract read
In one paragraph

Article in JMIR AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carlos Gallardo-GarcíaBioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Avda Complutense 40, Madrid, 28040, Spain, 34 910672474.ORCID http://orcid.org/0000-0003-0741-4436
M Elena HernandoBioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Avda Complutense 40, Madrid, 28040, Spain, 34 910672474.ORCID http://orcid.org/0000-0001-6182-313X
David SubíasEndocrinology and Nutrition Department, Parc Tauli Sabadell University Hospital, Institute of Research and Innovation Parc Tauli, Sabadell, Catalonia, Spain.ORCID http://orcid.org/0000-0003-3589-7842
Mercedes RiglaEndocrinology and Nutrition Department, Parc Tauli Sabadell University Hospital, Institute of Research and Innovation Parc Tauli, Sabadell, Catalonia, Spain.ORCID http://orcid.org/0000-0002-6691-4871
Gema García-SáezBioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Avda Complutense 40, Madrid, 28040, Spain, 34 910672474.ORCID http://orcid.org/0000-0002-8396-8185

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Type 1 diabetes is characterized by absolute insulin deficiency, requiring exogenous insulin therapy to maintain blood glucose levels within safe ranges. Postprandial glucose control remains particularly challenging, and current meal-related strategies are mainly based on carbohydrate intake. However, other macronutrients, such as fats and proteins, may also influence the magnitude and timing of the glycemic response and are not usually incorporated into glucose forecasting models. Objective: This study aims to develop and evaluate multihorizon blood glucose forecasting models to assess the impact of incorporating detailed nutritional information, with particular emphasis on the postprandial period and to analyze how the contribution of different nutrients varies across prediction horizons. Methods: We trained temporal fusion transformer (TFT) models on continuous glucose monitoring, insulin, and meal data with different combinations of nutritional variables from 351 adults with type 1 diabetes (15,601 meals) to predict glucose values up to 4 hours ahead. Carbohydrates were used as the baseline nutritional input, and additional configurations included fats, proteins, sugars, and complex carbohydrates. Model performance was evaluated globally and in predictions initiated at meal intake. Prediction horizons were grouped into early and late intervals, corresponding to 0-2 hours and 2-4 hours, respectively. The interpretability mechanisms of the TFT and integrated gradients method were used to analyze the relative contribution of nutritional variables. Results: Models incorporating additional nutritional information generally outperformed the carbohydrate-only baseline. In the global analysis, the combination of carbohydrates, fats, and proteins achieved the best performance in the early prediction interval, reducing mean root mean squared error (RMSE) and mean absolute error (MAE) from 30.48 mg/dL and 21.02 mg/dL to 29.23 mg/dL and 20.15 mg/dL. At late intervals, distinguishing between complex carbohydrates and sugars, together with fats and proteins, provided the best performance, reducing mean RMSE and MAE from 45.34 mg/dL and 34.73 mg/dL to 43.24 mg/dL and 32.65 mg/dL. A similar temporal dependency pattern was observed in the postprandial evaluation and was partially supported by the interpretability analysis. Conclusions: These findings suggest that incorporating a more comprehensive representation of meal composition may modestly improve postprandial glucose forecasting. Horizon-specific attribution patterns indicated that the models used nutritional inputs differently across the forecast horizon; however, these findings should not be interpreted as causal or physiological effects of individual nutrients. Further external and prospective validation is required before the potential clinical utility of these models can be assessed.

Indexed as

attention modelclinical decision-supportdeep learningexplainable artificial intelligenceglucose forecastingmultihorizon predictionnutritional informationtemporal fusion transformertype 1 diabetes

Identifiers

PMID42766712
PMCPMC13592460

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.